argenx SE (ARGX) Stock Forecast, Price Target & Predictions


OverviewOwnershipChartTranscripts

ARGX Stock Forecast


argenx SE (ARGX) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $1,067.78, with a high of $1,291.00 and a low of $858.00. This represents a 18.78% increase from the last price of $898.94.

$350 $540 $730 $920 $1 $1 High: $1291 Avg: $1067.78 Low: $858 Last Closed Price: $898.94

ARGX Stock Rating


argenx SE stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 1 Strong Buy (2.78%), 30 Buy (83.33%), 5 Hold (13.89%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 36 5 30 1 Strong Sell Sell Hold Buy Strong Buy

ARGX Price Target Upside V Benchmarks


TypeNameUpside
Stockargenx SE18.78%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends


1M3M12M
# Anlaysts3729
Avg Price Target$1.16K$1.18K$1.05K
Last Closing Price$898.94$898.94$898.94
Upside/Downside29.26%31.47%16.38%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 266153--24
May, 266153--24
Apr, 265153--23
Mar, 265152-123
Feb, 265151-122
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 04, 2026Douglas TsaoH.C. Wainwright$940.00$813.1415.60%4.57%
Jun 01, 2026Wells Fargo$1.29K$835.9954.43%43.61%
May 28, 2026Alex ThompsonStifel Nicolaus$1.25K$838.4949.67%39.61%
May 08, 2026Sean LaamanMorgan Stanley$1.17K$788.7348.34%30.15%
May 08, 2026Yatin SunejaGuggenheim$1.14K$787.3144.16%26.26%
May 08, 2026Wells Fargo$1.26K$787.3160.04%40.17%
May 07, 2026Stifel Nicolaus$1.22K$784.9655.68%35.94%
Feb 26, 2026Alex ThompsonStifel Nicolaus$1.23K$769.9859.35%36.49%
Jan 20, 2026Wells Fargo$1.32K$800.0164.62%46.51%
Jan 08, 2026Danielle BrillTruist Financial$1.03K$822.9425.16%14.58%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Jun 04, 2026H.C. WainwrightBuyBuyhold
Jun 01, 2026Wells FargoOverweightOverweighthold
May 28, 2026Rodman & RenshawBuydowngrade
May 08, 2026Morgan StanleyOverweightOverweighthold
May 08, 2026GuggenheimBuyBuyhold
May 08, 2026Wells FargoOverweightOverweighthold
Mar 13, 2026Cowen & Co.BuyBuyhold
Feb 26, 2026Bank of America SecuritiesBuyBuyhold
Jan 20, 2026Wells FargoOverweightOverweighthold
Jan 12, 2026William BlairOutperformOutperformhold

Financial Forecast


EPS Forecast

$-20 $-7 $6 $19 $32 $45 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-7.99$-13.05$-5.16-----
Avg Forecast$-6.93$-13.84$-4.27$2.19$9.99$18.54$26.94$34.47
High Forecast$-6.13$-10.14$-3.65$3.24$17.75$35.69$34.50$42.05
Low Forecast$-8.38$-16.90$-6.65$0.91$3.87$7.41$13.79$24.60
Surprise %15.30%-5.71%20.84%-----

Revenue Forecast

$0 $2B $3B $5B $6B $8B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$497.28M$410.75M$1.23B-----
Avg Forecast$510.21M$441.26M$1.21B$2.17B$3.32B$4.40B$5.38B$6.49B
High Forecast$592.33M$516.41M$1.22B$2.20B$3.80B$4.52B$5.54B$7.58B
Low Forecast$464.78M$350.58M$1.18B$2.14B$2.82B$4.28B$5.21B$5.06B
Surprise %-2.54%-6.92%1.38%-----

Net Income Forecast

$-1B $-300M $400M $1B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-408.26M$-709.59M$-295.05M-----
Avg Forecast$-396.15M$-173.12M$-268.11M$118.49M$647.04M$1.30B$1.79B$1.97B
High Forecast$-350.29M$-54.70M$-84.72M$185.18M$1.01B$2.04B$1.97B$2.40B
Low Forecast$-479.04M$-291.53M$-451.51M$51.81M$221.00M$423.47M$788.32M$1.41B
Surprise %3.06%309.90%10.05%-----

ARGX Forecast FAQ


Is argenx SE stock a buy?

argenx SE stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 30 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that argenx SE is a favorable investment for most analysts.

What is argenx SE's price target?

argenx SE's price target, set by 36 Wall Street analysts, averages $1.07K over the next 12 months. The price target range spans from $858 at the low end to $1.29K at the high end, suggesting a potential 18.78% change from the previous closing price of $898.94.

How does argenx SE stock forecast compare to its benchmarks?

argenx SE's stock forecast shows a 18.78% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for argenx SE over the past three months?

  • June 2026: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 21.74% Strong Buy, 65.22% Buy, 13.04% Hold, 0% Sell, 0% Strong Sell.

What is argenx SE’s EPS forecast?

argenx SE's average annual EPS forecast for its fiscal year ending in December 2024 is $2.19, marking a -142.44% decrease from the reported $-5.16 in 2023. Estimates for the following years are $9.99 in 2025, $18.54 in 2026, $26.94 in 2027, and $34.47 in 2028.

What is argenx SE’s revenue forecast?

argenx SE's average annual revenue forecast for its fiscal year ending in December 2024 is $2.17B, reflecting a 76.93% increase from the reported $1.23B in 2023. The forecast for 2025 is $3.32B, followed by $4.4B for 2026, $5.38B for 2027, and $6.49B for 2028.

What is argenx SE’s net income forecast?

argenx SE's net income forecast for the fiscal year ending in December 2024 stands at $118.49M, representing a -140.16% decrease from the reported $-295M in 2023. Projections indicate $647.04M in 2025, $1.3B in 2026, $1.79B in 2027, and $1.97B in 2028.